Skin toxicity and quality of life in patients with metastatic colorectal cancer during first-line panitumumab plus FOLFIRI treatment in a single-arm phase II study

BACKGROUND: Integument-related toxicities are common during epidermal growth factor receptor (EGFR)-targeted therapy. Panitumumab is a fully human monoclonal antibody targeting the EGFR that significantly improves progression-free survival when added to chemotherapy in patients with metastatic color...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Thaler, Josef, Karthaus, Meinolf, Mineur, Laurent, Greil, Richard, Letocha, Henry, Hofheinz, Ralf, Fernebro, Eva, Gamelin, Erick, Baños, Ana, Köhne, Claus-Henning
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2012
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3520865/
https://ncbi.nlm.nih.gov/pubmed/23020584
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-12-438
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados